Dan Dearen

Dan Dearen is an accomplished financial executive with extensive experience in the medical technology sector. Currently serving as an Independent Board Member and Chair of the Audit Committee for Beta Bionics and JenaValve Technology, Dan has previously held similar roles at Endotronix and has a rich history in leadership positions, including President and CFO of Axonics, where the company was acquired by Boston Scientific for $3.7 billion. Dan's career also includes senior roles at Boston Scientific, Miraval Arizona, and Q3DM, showcasing expertise in strategic planning, business development, and turnaround strategies across various organizations. Educational achievements include a Bachelor of Business Administration from Southern Methodist University, an MBA from Boston College, and an accredited director certification from UCLA.